Even after they beat analysts expectations they never changed their forcast. They should have increased their eps for this quarter to 6 cents because last quarters result was not a one time gain. Concidering the new pharmacy and injection center along with the new contract to rent chairs the will have growth this quarter. If they show gains from these new developments they may come in at 7 cents a share. They finally put out the second quarter estimate for 6 cents a share. Its great they pulled their thumbs out their a-- long enough to get it out there although it is probably wrong. lol Maybe this will become the new market leader so get what you can at this price.